Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 11, Pages 454-457
http://dx.doi.org/10.1100/tsw.2011.61
Opinion Paper

Pharma TARP: A Troubled Asset Relief Program for Novel, Abandoned Projects in the Pharmaceutical Industry

1Molecular and Integrative Neurosciences Department, The Scripps Research Institute, La Jolla, CA, USA
2TheScientificWorld, Kirkkonummi, Finland

Received 6 February 2011; Revised 9 February 2011; Accepted 10 February 2011

Copyright © 2011 Tamas Bartfai and Graham Vaughan Lees.

Citations to this Article [8 citations]

The following is the list of published articles that have cited the current article.

  • David J. Eve, Cesar V. Borlongan, and Paul R. Sanberg, “A Showcase of Bench-to-Bedside Regenerative Medicine at the 2010 ASNTR,” The Scientific World JOURNAL, vol. 11, pp. 1842–1864, 2011. View at Publisher · View at Google Scholar
  • Graham V. Lees, and Tamas Bartfaipp. 1–346, 2013. View at Publisher · View at Google Scholar
  • Fabrizio Benedetti, Elisa Carlino, and Alessandro Piedimonte, “Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effects,” Lancet Neurology, vol. 15, no. 7, pp. 736–747, 2016. View at Publisher · View at Google Scholar
  • Alessandro Piedimonte, Fabrizio Benedetti, and Elisa Carlino, “Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effects,” The Lancet Neurology, vol. 15, no. 7, pp. 736–747, 2016. View at Publisher · View at Google Scholar
  • Aziz Shaibani, Elisa Frisaldi, and Fabrizio Benedetti, “Placebo response in pain, fatigue, and performance: Possible implications for neuromuscular disorders,” Muscle & Nerve, 2017. View at Publisher · View at Google Scholar
  • Elisa Frisaldi, Aziz Shaibani, and Fabrizio Benedetti, “Why We should Assess Patients’ Expectations in Clinical Trials,” Pain and Therapy, 2017. View at Publisher · View at Google Scholar
  • Fabrizio Benedetti, Elisa Carlino, and Alessandro Piedimonte, “Placebos in clinical trials: unravelling a complex phenomenon – Authors' reply,” The Lancet Neurology, vol. 16, no. 1, pp. 29, 2017. View at Publisher · View at Google Scholar
  • Emily G. Severance, Faith B. Dickerson, and Robert H. Yolken, “Autoimmune phenotypes in schizophrenia reveal novel treatment targets,” Pharmacology & Therapeutics, 2018. View at Publisher · View at Google Scholar